Dosage and administration
Adults and children 2 years and older: apply to affected areas one to four times daily, or as directed by a doctor. Children under 2 years: ask a doctor.
Adults and children 2 years and older: apply to affected areas one to four times daily, or as directed by a doctor. Children under 2 years: ask a doctor.
store at 15-25 ℃
Salicylic Acid 2%
seborrheic dermatitis, psoriasis
For relief of skin itching, irritation, redness, flaking, and scaling associated with seborrheic dermatitis and psoriasis.
For external use only.
If condition covers a large area of the body, consult your doctor before using this product.
On the eye area.
On children under 2 years of age except under the advice of a doctor.
Avoid contact with the eyes. If contact occurs, rinse the eyes thoroughly with water.
condition worsens or does not improve after regular use as directed.
Irritation or rash occurs.
If swallowed, get medical help or contact a Poison Control Center right away.
Adults and children 2 years and older: apply to affected areas one to four times daily, or as directed by a doctor.
Children under 2 years: ask a doctor.
store at 15-25 ℃
Water, Glycerin, Aloe Vera, Sodium Hyaluronate, Allantoin, Herba Violae, Sophora Flavescens Root, Cortex Dictamni, Phellodendron Amurense Rupr., Stemona Tuberosa Lour, Mentha Canadensis L., Phenoxyethanol.
info@pureskinsupport.com
www.pureskinsupport.com
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 87217-003 | 87217-003-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pureskin Seborrheic Dermatitis and Psoriasis Cream | SEBORRHEIC DERMATITIS PSORIASIS CREAM | BENLONG HALL LLC | 36086f7f-8536-417f-a302-37f78288489e | 2026-07-20 | Warnings | 87217-003-01 87217-003 87217000301 570f8dd1-3691-c267-e063-6394a90a031e 36086f7f-8536-417f-a302-37f78288489e |
Adverse event summaries are temporarily unavailable. Other product information remains available.